Discontinuation report ACETAMINOPHEN, CAFFEINE & CODEINE
| Report ID | 117751 |
| Drug Identification Number | 02028174 |
| Brand name | ACETAMINOPHEN, CAFFEINE & CODEINE |
| Common or Proper name | ACETAMINOPHEN, CAFFEINE & CODEINE |
| Company Name | PHARMASCIENCE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ACETAMINOPHEN CAFFEINE CODEINE PHOSPHATE |
| Strength(s) | 300MG 15MG 8MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100, 200 |
| ATC code | N02AJ |
| ATC description | OPIOIDS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2020-06-15 |
| Actual discontinuation date | 2020-06-15 |
| Remaining supply date | 2020-06-12 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Product already discontinued - DIN cancelled post market |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2021-10-27 | French | Compare |
| v3 | 2021-10-27 | English | Compare |
| v2 | 2020-06-15 | French | Compare |
| v1 | 2020-06-15 | English | Compare |
Showing 1 to 4 of 4